Ann: Shareholder Update March 2018, page-30

Let's hope Steve ensures real 'good faith' demonstrated in the benefits flowing from agreeing to give p&g access to obj's closest-held know-how, because it wasn't much in evidence when p&g screwed fledgling obj to the wall in the first deal.

Imagine what p&g negotiators would have wrung out of an agreement for them to supply a tech to triple the effect of a goo made by others. They would have had a clause to benefit from increased goo sales, that's for sure.

Bodyguard - now forking off onto the long, rocky FDA path - enough said.